The ICF Classification System to Assess Risk Factors for CVD in Secondary Prevention after Ischemic Stroke and
Mateusz Lucki1, Ewa Chlebuś2, Agnieszka Wareńczak2
1Department of Cardiology, Hospital Center of the Jelenia Góra Valley, 58-506 Jelenia Góra, Poland.
Insights
Patients with prior stroke face high risks for new cardiovascular events (CVD). This study found different risk factors for recurrent CVD based on stroke type, aiding secondary prevention strategies.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Patients with a history of stroke are at elevated risk for subsequent cardiovascular events (CVD).
- Effective secondary prevention strategies are crucial for this high-risk population.
- Understanding stroke-type specific risk factors is key to improving outcomes.
Purpose of the Study:
- To investigate differences in risk factor incidence for recurrent CVD based on the clinical type of prior stroke.
- To characterize these risk factors using the International Classification of Functioning, Disability and Health (ICF) system.
Main Methods:
- Retrospective analysis of risk factors for recurrent CVD events.
- Study included 109 patients with ischemic stroke (IS) and 80 patients with intracerebral hemorrhage (ICH).
- Data collected within 14 days poststroke.
Main Results:
- Ischemic stroke patients had higher rates of atrial fibrillation/flutter, >70% carotid stenosis, hypertension (>140/90 mmHg), elevated HbA1c (>7%), smoking, and NSAID use.
- Hemorrhagic stroke patients showed more frequent liver function test abnormalities.
- Statistical significance was observed for all reported differences (p < 0.05).
Conclusions:
- The incidence and types of CVD risk factors differ significantly between ischemic stroke and intracerebral hemorrhage.
- The ICF classification system provides a valuable framework for assessing these varied risk factors.
- Tailoring secondary prevention based on stroke type can help mitigate the risk of recurrent CVD events.
Abstract:
Background and objectives: Patients with a history of prior stroke have a high risk for subsequent cardiovascular events (CVD). Therefore, the implementation of an effective strategy to reduce risk factors and thereby improve secondary prevention outcomes is crucial in this patient population. The aim of this study was to determine differences in the incidence of risk factors for recurrent CVD events based on clinical type of prior stroke and to characterize them using the ICF (International Classification of Functioning, Disability and Health) classification system. Materials and Methods: The incidence of risk factors for recurrent CVD events were retrospectively analyzed in 109 patients with a history of ischemic stroke (IS) and 80 patients with a history of intracerebral hemorrhage (ICH) within 14 days poststroke. Results: Atrial fibrillation/flutter (p = 0.031), >70% carotid artery stenosis (p = 0.004), blood pressure >140/90 mmHg (p = 0.025), blood HbA1c levels >7% (p = 0.002), smoking (p = 0.026) and NSAID (nonsteroidal anti-inflammatory drug) use (p < 0.001) were significantly more common in patients with a history of ischemic stroke. However, liver function test abnormalities were observed more commonly in patients with a history of hemorrhagic stroke (p = 0.025). Conclusions: The incidence and type of risk factors for recurrent CVD events vary according to the clinical type of prior stroke. The ICF classification system is a useful tool for evaluating these risk factors. This may help reduce the risk of subsequent CVD events.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:27Heart Failure I: Introduction
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:26Coronary Artery Disease IV: Preventive Measures